Total Payments
$3,226
2024 Payments
$404.41
Companies
19
Transactions
83
Medicare Patients
908
Medicare Billing
$277,394
Payment Breakdown by Category
Food & Beverage$2,880 (89.3%)
Travel$285.90 (8.9%)
Education$59.50 (1.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,880 | 80 | 89.3% |
| Travel and Lodging | $285.90 | 2 | 8.9% |
| Education | $59.50 | 1 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $699.65 | 13 | $0 (2024) |
| Shionogi Inc | $506.27 | 6 | $0 (2024) |
| Boston Scientific Corporation | $319.76 | 3 | $0 (2019) |
| Chiesi USA, Inc. | $278.85 | 14 | $0 (2024) |
| La Jolla Pharmaceutical Company | $238.30 | 4 | $0 (2024) |
| Gilead Sciences, Inc. | $221.41 | 2 | $0 (2024) |
| Jazz Pharmaceuticals Inc. | $187.34 | 4 | $0 (2018) |
| CSL Behring | $186.10 | 6 | $0 (2023) |
| ABBVIE INC. | $143.98 | 9 | $0 (2024) |
| Melinta Therapeutics, LLC | $116.85 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $404.41 | 12 | Gilead Sciences, Inc. ($121.83) |
| 2023 | $786.71 | 25 | Shionogi Inc ($249.70) |
| 2022 | $449.11 | 21 | Shionogi Inc ($146.92) |
| 2021 | $766.49 | 13 | AstraZeneca Pharmaceuticals LP ($365.89) |
| 2020 | $234.47 | 4 | AstraZeneca Pharmaceuticals LP ($207.42) |
| 2019 | $319.76 | 3 | Boston Scientific Corporation ($319.76) |
| 2018 | $205.07 | 4 | Jazz Pharmaceuticals Inc. ($127.84) |
| 2017 | $59.50 | 1 | Jazz Pharmaceuticals Inc. ($59.50) |
All Payment Transactions
83 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Chiesi USA, Inc. | CLEVIPREX (Drug), KENGREAL | Food and Beverage | Cash or cash equivalent | $14.91 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/15/2024 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $19.09 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/10/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $19.45 | General |
| 10/02/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 09/19/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: VTE | ||||||
| 09/11/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: COVID-19 | ||||||
| 09/10/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $109.65 | General |
| Category: Infections and Infectious Diseases | ||||||
| 07/29/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Rare Disease | ||||||
| 05/06/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 03/11/2024 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/26/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Rare Disease | ||||||
| 01/18/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/18/2023 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Infections and Infectious Diseases | ||||||
| 12/12/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Rare Disease | ||||||
| 10/18/2023 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $124.70 | General |
| Category: Infections and Infectious Diseases | ||||||
| 10/05/2023 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/02/2023 | Melinta Therapeutics, LLC | Rezzayo (Drug), Kimyrsa, Orbactiv | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: ANTIFUNGALS | ||||||
| 09/28/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Iron Deficiency Anemia | ||||||
| 09/18/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Rare Disease | ||||||
| 08/24/2023 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $118.48 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 08/19/2023 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 08/08/2023 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $13.13 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/04/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/27/2023 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/24/2023 | Merck Sharp & Dohme LLC | ZERBAXA (Drug), RECARBRIO | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 234 | 486 | $455,884 | $72,655 |
| 2022 | 3 | 229 | 489 | $494,291 | $73,366 |
| 2021 | 5 | 236 | 458 | $481,474 | $76,547 |
| 2020 | 4 | 209 | 397 | $495,911 | $54,826 |
Total Patients
908
Total Services
1,830
Medicare Billing
$277,394
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 123 | 310 | $375,150 | $55,166 | 14.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 60 | 110 | $47,976 | $11,089 | 23.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $14,229 | $2,520 | 17.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 35 | $10,535 | $2,367 | 22.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 14 | $7,994 | $1,512 | 18.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 141 | 331 | $414,569 | $58,060 | 14.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 65 | 135 | $59,729 | $11,589 | 19.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 23 | 23 | $19,993 | $3,717 | 18.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 137 | 332 | $397,684 | $62,610 | 15.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 46 | 55 | $45,232 | $8,895 | 19.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 21 | 38 | $16,738 | $3,036 | 18.1% |
| 36556 | Insertion of central venous catheter for infusion, patient 5 years or older, not tunneled | Facility | 2021 | 20 | 21 | $19,468 | $1,546 | 7.9% |
| 36620 | Insertion of arterial catheter for blood sampling or infusion, accessed through the skin | Facility | 2021 | 12 | 12 | $2,352 | $460.56 | 19.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 79 | 183 | $306,085 | $35,488 | 11.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 80 | 149 | $137,815 | $13,295 | 9.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 16 | 18 | $14,928 | $3,247 | 21.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 34 | 47 | $37,083 | $2,796 | 7.5% |
About Bilal Khan
Bilal Khan is a Pulmonary Disease healthcare provider based in Livingston, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/28/2014. The National Provider Identifier (NPI) number assigned to this provider is 1013330091.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Bilal Khan has received a total of $3,226 in payments from pharmaceutical and medical device companies, with $404.41 received in 2024. These payments were reported across 83 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,880).
As a Medicare-enrolled provider, Khan has provided services to 908 Medicare beneficiaries, totaling 1,830 services with total Medicare billing of $277,394. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine, Internal Medicine
- Location Livingston, NJ
- Active Since 01/28/2014
- Last Updated 04/30/2024
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1013330091
Products in Payments
- LOKELMA (Drug) $587.78
- Fetroja (Drug) $506.27
- GENERAL PULMONARY (Device) $319.76
- GIAPREZA (Drug) $238.30
- Veklury (Drug) $221.41
- CLEVIPREX (Drug) $209.00
- Xyrem (Drug) $187.34
- Kcentra (Biological) $186.10
- ANDEXXA (Biological) $99.18
- Vabomere (Drug) $89.67
- AVYCAZ (Drug) $84.83
- KENGREAL (Drug) $69.85
- ULTOMIRIS (Biological) $61.49
- DALVANCE (Drug) $59.15
- XARELTO (Drug) $49.38
- ZERBAXA (Drug) $44.43
- TE7 MAX (Device) $43.87
- Rezzayo (Drug) $27.18
- DIFICID (Drug) $23.62
- FLOWTRIEVER CATHETER, S (Device) $23.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Livingston
Dr. Kristin Fless, M.d, M.D
Pulmonary Disease — Payments: $7,799
Pulmonary Disease $7,799
Elena Burke, M.d, M.D
Pulmonary Disease — Payments: $1,862
Pulmonary Disease $1,862
Kenneth Defusco, Md, MD
Pulmonary Disease — Payments: $883.85
Pulmonary Disease $883.85
Dr. Martin Greenberg, M.d, M.D
Pulmonary Disease — Payments: $665.14
Pulmonary Disease $665.14